Evaluating endometrial response to human chorionic gonadotropin: alterations in epigenetic regulation and extracellular vesicle cargo of endometrial stromal cells
article
OA: gold
CC0
AI-generated summary
Human chorionic gonadotropin treatment alters endometrial stromal cell epigenetic regulation and extracellular vesicle cargo, influencing implantation and immune response through modified protein and microRNA levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY QUESTION: What is the effect of hCG on the epigenetic profile and the expression of other molecular factors in endometrial stromal cells (ESCs)? SUMMARY ANSWER: Our findings suggest that hCG treatment alters the molecular environment of decidualized ESCs, potentially influencing implantation and immune regulation through epigenetic modifications and changes in the levels of secreted proteins and micro-ribonucleic acids (miRNAs). WHAT IS KNOWN ALREADY: Embryo implantation depends not only on the quality of the embryo but also on the receptivity of the endometrium, the specialized lining of the uterus that undergoes dynamic changes to support pregnancy. Effective communication between the maternal and fetal compartments, facilitated by molecular signals and cellular interactions, is essential for successful implantation. STUDY DESIGN SIZE DURATION: Cross-sectional study of patient-derived ESCs comparing untreated cells with cells treated with hCG and/or decidualization induction. The number of samples depends on the method and varies from 2 to 8. Results were analyzed after 6-, 24-, 48-, and 72-h time-points. PARTICIPANTS/MATERIALS SETTING METHODS: response to the embryo-secreted factor, hCG. ESCs were induced for decidualization for 3 days (medroxyprogesterone acetate+cAMP), or treated with hCG for 24 h, or given combined treatment: 2 days of decidualization followed by 24 h of hCG. Furthermore, we compared decidualized ESCs with decidualized ESCs that were also treated with hCG. We examined various cellular properties, including morphology, metabolic activity, and cell viability of ESCs after induction of decidualization and hCG treatment. Additionally, we assessed changes in the expression of genes associated with decidualization, inflammatory response, apoptosis regulation, and epigenetic factors using RT-qPCR. The levels of histone modifications and the factors regulating these modifications were explored by performing western blot assays. Additionally, we performed a chromatin immunoprecipitation assay to extract gene regions enriched with the epigenetic modification H3K27Ac. Finally, we analyzed the protein and miRNA level changes in ESC extracellular vesicles (ESC-EVs) after the indicated treatments, using mass spectrometry and small RNA sequencing. MAIN RESULTS AND THE ROLE OF CHANCE: < 0.05). LARGE SCALE DATA: N/A. LIMITATIONS REASONS FOR CAUTION: samples. Future studies involving a broader range of cell types and larger sample sizes could help to further validate and expand upon these results. WIDER IMPLICATIONS OF THE FINDINGS: We found that hCG enhances the decidualization process in a dose-dependent manner and affects implantation and immune regulation through epigenetic changes, as well as variations in the levels of secreted proteins and miRNAs. Our study suggests that the application of hCG in assisted reproduction technologies may offer potential benefits for patients. However, carefully considering the appropriate dosage is important to ensure optimal outcomes. STUDY FUNDING/COMPETING INTERESTS: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors have no conflicts of interest to declare.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Decidualization of the human endometrium 2018
- Human chorionic gonadotropin induces decidualization of ectopic human endometrium more effectively than forskolin in an <i>in-vivo</i> endometriosis model 2018
- hCG activates Epac-Erk1/2 signaling regulating Progesterone Receptor expression and function in human endometrial stromal cells 2017
References (65)
- Decidualization of the human endometrium via openalex
- hCG activates Epac-Erk1/2 signaling regulating Progesterone Receptor expression and function in human endometrial stromal cells via openalex
- Human chorionic gonadotropin induces decidualization of ectopic human endometrium more effectively than forskolin in an <i>in-vivo</i> endometriosis model via openalex
- doi:10.1530/rep-19-0559 via openalex
- doi:10.1186/s13059-014-0550-8 via openalex
- doi:10.3390/ijms21061973 via openalex
- doi:10.3390/ijms21114092 via openalex
- doi:10.1093/bioinformatics/bti430 via openalex
- doi:10.1055/s-0029-1237423 via openalex
- doi:10.1186/gb-2009-10-3-r25 via openalex
- doi:10.1093/molehr/gaaa026 via openalex
- doi:10.1371/journal.pone.0015224 via openalex
- doi:10.1038/s41598-020-62593-9 via openalex
- doi:10.1007/s00404-018-4923-1 via openalex
- doi:10.1080/15384101.2020.1870335 via openalex
- doi:10.1371/journal.pone.0240012 via openalex
- doi:10.1093/humrep/det136 via openalex
- doi:10.3390/diagnostics11030480 via openalex
- doi:10.1007/s10815-018-1248-8 via openalex
- doi:10.4103/jhrs.jhrs_196_20 via openalex
- doi:10.21769/bioprotoc.2693 via openalex
- doi:10.3390/ijms18061305 via openalex
- doi:10.1111/aji.13360 via openalex
- doi:10.1155/2020/8892930 via openalex
- doi:10.1007/s00109-021-02042-w via openalex
- doi:10.1186/s12884-021-04110-y via openalex
- doi:10.1007/s00404-019-05346-y via openalex
- doi:10.1262/jrd.2014-115 via openalex
- doi:10.1152/ajpregu.00034.2013 via openalex
- doi:10.3390/genes11040376 via openalex
- doi:10.1016/j.rbmo.2021.06.011 via openalex
- doi:10.18637/jss.v025.i01 via openalex
- doi:10.1016/j.fertnstert.2007.08.023 via openalex
- doi:10.3389/fphys.2022.893744 via openalex
- doi:10.1016/j.biocel.2023.106362 via openalex
- doi:10.1016/j.rbmo.2024.103990 via openalex
- doi:10.3390/ijms242417616 via openalex
- doi:10.1016/j.theriogenology.2024.03.016 via openalex
- doi:10.1038/s41598-022-12495-9 via openalex
- doi:10.1016/j.repbio.2022.100645 via openalex
- doi:10.1530/rep-21-0501 via openalex
- doi:10.3390/ijms23031380 via openalex
- doi:10.1186/s40001-023-01459-y via openalex
- doi:10.1186/s13287-024-03846-6 via openalex
- doi:10.1096/fj.202200849r via openalex
- doi:10.1038/s41591-024-02936-5 via openalex
- doi:10.1038/s41598-024-68108-0 via openalex
- doi:10.1093/humupd/dmab028 via openalex
- doi:10.1016/j.amsu.2022.104091 via openalex
- doi:10.1371/journal.pone.0064829 via openalex
- doi:10.3390/ijms20020425 via openalex
- doi:10.1534/genetics.114.173492 via openalex
- doi:10.1038/cdd.2016.31 via openalex
- doi:10.1038/cmi.2017.107 via openalex
- doi:10.1186/1477-7827-6-6 via openalex
- doi:10.3390/biomedicines7040083 via openalex
- doi:10.1186/s13072-023-00485-8 via openalex
- doi:10.1093/biolre/ioaa013 via openalex
- doi:10.3389/fcell.2022.1078096 via openalex
- doi:10.1210/endrev/bnad017 via openalex
- doi:10.1093/humrep/det055 via openalex
- doi:10.3389/fcell.2020.586479 via openalex
- doi:10.1093/humrep/dew080 via openalex
- doi:10.1007/s00404-019-05047-6 via openalex
- doi:10.1002/rmb2.12023 via openalex
Source provenance
- openalex
- last seen: 2026-05-14T06:28:07.472223+00:00
License: CC0
· commercial use OK